About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
Previous Close | $0.92 | Open | $0.92 |
Volume | 12.59M | Market Cap | 18.46M |
Yield | Last Dividend |
Are You Following Analysts On These Penn... | 01/15/21 |
This year has gotten off to a strong start already. Many stocks, including penny stocks , are reaching new 52-week and all-time highs. Meanwhile, the ... |
Synthetic Biologics: 6 Things for SYN St... | 01/05/21 |
Synthetic Biologics (SYN) stock is soaring higher on heavy trading Tuesday even without a lack of news concerning the company. |
Synthetic Biologics Announces Extension ... | 11/24/20 |
ROCKVILLE, Md., Nov. 24, 2020 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the micr... |
Synthetic Biologics Engages A.G.P./Allia... | 11/16/20 |
ROCKVILLE, Md., Nov. 16, 2020 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the micr... |
Synthetic Biologics Welcomes Senior Biot... | 11/12/20 |
ROCKVILLE, Md., Nov. 12, 2020 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the micr... |
Synthetic Biologics to Report 2020 Third... | 11/03/20 |
ROCKVILLE, Md., Nov. 3, 2020 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the micro... |
Synthetic Biologics (NYSEAMERICAN:SYN) S... | 10/23/20 |
Synthetic Biologics, Inc. (NYSEAMERICAN:SYN) shares rose 16.3% during mid-day trading on Friday . The stock traded as high as $0.48 and last traded at... |
Human Microbiome Market predicted to rea... | 10/13/20 |
This research report will give you deep insights about the Human Microbiome Market and it will also help you in strategic decision making. The final r... |
Synthetic Biologics Reports 2020 Second ... | 08/06/20 |
ROCKVILLE, Md., Aug. 6, 2020 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the micro... |
Synthetic Biologics Announces Submission... | 06/30/20 |
ROCKVILLE, Md., June 30, 2020 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the micr... |
Synthetic Biologics Reports 2020 First Q... | 05/05/20 |
ROCKVILLE, Md., May 5, 2020 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microb... |
The Week Ahead In Biotech: Smid-Cap Earn... | 05/03/20 |
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma nam... |
The right prescription to kickstart Indi... | 04/14/20 |
Many businesses having been left with zero revenue for one-and-a-half months, the Indian economy will struggle to recover even when the generalised lo... |
Labs experiment with new and unproven me... | 03/30/20 |
The coronavirus has ground social, economic, and educational exchanges to a halt around the world. For now, public health officials are relying on too... |
The Agricultural Biotechnology Industry ... | 03/27/20 |
DUBLIN--(BUSINESS WIRE)--The "Agricultural Biotechnology: Emerging Technologies and Global Markets" report has been added to ResearchAndMarkets.com's ... |
Synthetic Biologics Reports 2019 Year En... | 02/20/20 |
ROCKVILLE, Md., Feb. 20, 2020 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the micr... |
Smoking Gun? Chinese Scientist Finds "Ki... | 02/14/20 |
Smoking Gun? Chinese Scientist Finds "Killer Coronavirus Probably Originated From A Laboratory In Wuhan" The uncertainty and the debate over the origi... |
Synthetic Biologics to Report 2019 Year ... | 02/13/20 |
ROCKVILLE, Md., Feb. 13, 2020 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the micr... |
Synthetic Biologics to Present at the 20... | 02/04/20 |
ROCKVILLE, Md., Feb. 4, 2020 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the micro... |
Synthetic Biologics Receives FDA Guidanc... | 01/07/20 |
/PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics... |
Synthetic Biology Industry Outlook to 20... | 12/23/19 |
DUBLIN--(BUSINESS WIRE)--The "Synthetic Biology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The study scope includes ... |
Is Synthetic Biologics Inc (SYN) Going T... | 11/30/19 |
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing. Truth be told, most hedge fund managers and o... |
Synthetic Biologics to Report 2019 Third... | 10/28/19 |
ROCKVILLE, Md., Oct. 28, 2019 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the micr... |
Silicon Valley's top startup hub just te... | 09/16/19 |
On Monday, the startup hub Y Combinator and the $1.4 billion company Ginkgo Bioworks unveiled a new partnership aimed at giving startups access to too... |
Got Impossible Milk? The Quest for Lab-M... | 08/02/19 |
With advances in synthetic biology, researchers and entrepreneurs strive to create cows??? milk without cows. |
The Promise and Perils of Designer Genes | 08/01/19 |
Synthetic biology is expanding on an industrial scale, offering the hope of tailormade microbes???and the threat of global destruction, argues journal... |
Matter: Scientists Created Bacteria With... | 05/15/19 |
In a milestone for synthetic biology, colonies of E. coli thrive with DNA constructed from scratch by humans, not nature. |
Synthetic Biologics' (SYN) CEO Steven Sh... | 05/08/19 |
No summary available. |
Synthetic Biologics reports Q1 results | 05/08/19 |
No summary available. |
Synthetic Biologics reports FY results | 02/27/19 |
No summary available. |
Date | 2020-11-10 (AMC) | Est. (EPS/Rev.) | ($0.17)/ 0 |
Actual (EPS/Rev.) | $-0.14/ | EPS (TTM) | 0 |
Total Revenue | $1.3B | Total Liabilities | $2.1B |
Cost of Revenue | $2.5B | Total cash flow | $3.2 |
Total Assets | $29.98B |
% Insider | 12.52% | % Institutional | 76.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
Service Name | Trader | % Success | |
---|---|---|---|
Tech Trades | Tech Trades | 81.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.